231 filings
Page 7 of 12
6-K
dy084 aj6
2 Mar 21
Current report (foreign)
4:07pm
6-K
4g4ettu
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
dv6rwrclj
1 Mar 21
Current report (foreign)
4:00pm
6-K
aeilts
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
qaz450xky joagn1hc2w
17 Feb 21
Report of Foreign Private Issuer
8:35am
6-K
x07k3hz
11 Feb 21
SciSparc Announces Rebranding and Business Updates
10:01am
6-K
oa4pkquy
10 Feb 21
SciSparc Engages Procaps for Development and Production of CannAmideā¢ and its SCI-110 Product Candidate
8:33am
6-K
0i3jodd6
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmideā¢ Pills
8:36am
6-K
8fm2qzoe1qt9mkr wo4
28 Jan 21
Report of Foreign Private Issuer
9:36am
6-K
f1qamx oi6f68sq77
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
ku1thlj l3
7 Jan 21
Report of Foreign Private Issuer
5:00pm
6-K
wd9t6x0efg0rpxgp 6n
6 Jan 21
Report of Foreign Private Issuer
11:53am
6-K
mtf7b 3xtwqx
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
6-K
aht5q100 9mklxofkzx
31 Dec 20
Report of Foreign Private Issuer
2:02pm
6-K
uyn lfqi79zp
15 Dec 20
Report of Foreign Private Issuer
10:55am
6-K
ijaq7
8 Dec 20
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
9:36am
6-K
e8tdaszwd0lw1lde
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
syyvd41kkl0qr
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
6-K
c6duvm7ao nzz4k248hn
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
yyg1w mq51prmf
16 Oct 20
Report of Foreign Private Issuer
4:05pm